CATALYST PHARMACEUTICALS INC. - COMMON STOCK
21.48
22-November-24 16:44:58
15 minutes delayed
Stocks
+0.36
+1.70%
Today's range
21.05 - 21.55
ISIN
N/A
Source
NASDAQ
-
Catalyst Pharmaceuticals to Participate at the 2023 Cantor Global Healthcare Conference
18 Sep 2023 08:03:00 By Nasdaq GlobeNewswire
-
16 Aug 2023 10:56:47 By Nasdaq GlobeNewswire
-
14 Aug 2023 08:05:10 By Nasdaq GlobeNewswire
-
09 Aug 2023 16:17:05 By Nasdaq GlobeNewswire
-
19 Jul 2023 06:00:00 By Nasdaq GlobeNewswire
-
20 Jun 2023 06:00:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals Reports Positive Momentum in Second Quarter 2023
01 Jun 2023 08:03:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals Appoints Tamar Thompson to its Board of Directors
30 May 2023 08:03:00 By Nasdaq GlobeNewswire
-
10 May 2023 16:28:05 By Nasdaq GlobeNewswire
-
09 May 2023 08:03:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals Announces Release of Inaugural ESG Report
01 May 2023 08:03:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals to Report First Quarter 2023 Financial Results on May 10, 2023
24 Apr 2023 08:03:00 By Nasdaq GlobeNewswire
-
20 Apr 2023 08:03:00 By Nasdaq GlobeNewswire
-
15 Mar 2023 16:11:45 By Nasdaq GlobeNewswire
-
01 Mar 2023 08:03:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals to Ring the Nasdaq Closing Bell in Honor of International Rare Disease Day
22 Feb 2023 08:03:00 By Nasdaq GlobeNewswire
-
07 Feb 2023 08:03:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA® (Perampanel) CIII
25 Jan 2023 08:03:00 By Nasdaq GlobeNewswire